These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group. Stuart-Harris RC; Lauchlan R; Day R Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397 [TBL] [Abstract][Full Text] [Related]
5. Interferon in the treatment of AIDS-associated Kaposi's sarcoma: the American experience. Safai B; Bason M; Friedman-Birnbaum R; Nisce L J Invest Dermatol; 1990 Dec; 95(6 Suppl):166S-169S. PubMed ID: 1701804 [TBL] [Abstract][Full Text] [Related]
6. Current status of interferons in the treatment of cancer. Hansen RM; Borden EC Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153 [TBL] [Abstract][Full Text] [Related]
7. Interferons in dermatology. Present-day standard. Stadler R Dermatol Clin; 1998 Apr; 16(2):377-98. PubMed ID: 9589211 [TBL] [Abstract][Full Text] [Related]
8. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Jonasch E; Haluska FG Oncologist; 2001; 6(1):34-55. PubMed ID: 11161227 [TBL] [Abstract][Full Text] [Related]
10. Interferon. Hood LE Am J Nurs; 1987 Apr; 87(4):459-65. PubMed ID: 2436479 [No Abstract] [Full Text] [Related]
11. [Alpha interferons--new therapeutic modalities]. Bajcetić M; Zigon N; Samardzić R; Beleslin DB Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956 [TBL] [Abstract][Full Text] [Related]
12. Clinical use of biologic response modifiers in cancer treatment: an overview. Part I. The interferons. Balmer CM DICP; 1990; 24(7-8):761-8. PubMed ID: 1695795 [TBL] [Abstract][Full Text] [Related]
14. Biotherapy with interferon--1988. Figlin RA Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749 [TBL] [Abstract][Full Text] [Related]
15. [Current status of interferon therapy]. Dittrich C Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497 [TBL] [Abstract][Full Text] [Related]
16. [Interferons, interleukin-2 and tumor necrosis factor. New approaches to cancer therapy]. Oettgen HF Arzneimittelforschung; 1987 Feb; 37(2A):251-5. PubMed ID: 2436634 [TBL] [Abstract][Full Text] [Related]
17. AIDS and Kaposi's sarcoma: interferons in pathogenesis and treatment. Krown SE Interferon; 1986; 7():185-211. PubMed ID: 2434434 [No Abstract] [Full Text] [Related]
18. Update on the diagnosis of and therapy for acute promyelocytic leukemia and chronic myelogenous leukemia. Wujcik D Oncol Nurs Forum; 1996 Apr; 23(3):478-87. PubMed ID: 8801508 [TBL] [Abstract][Full Text] [Related]
19. Interleukins: the search for an anticancer therapy. Wheeler VS Semin Oncol Nurs; 1996 May; 12(2):106-14. PubMed ID: 8727798 [TBL] [Abstract][Full Text] [Related]